XML 20 R19.htm IDEA: XBRL DOCUMENT  v2.3.0.11
OPERATING SEGMENT AND GEOGRAPHIC INFORMATION
 6 Months Ended
Jun. 30, 2011
Operating Segment and Geographic Information [Abstract]  
Operating Segment And Geographic Information [Text Block]
OPERATING SEGMENT AND GEOGRAPHIC INFORMATION
Our company’s chief operating decision-maker is the Chief Executive Officer, who regularly evaluates our performance based on net sales and gross profit. The preparation of this segment analysis requires management to make estimates and assumptions around expense below the gross profit level. While we believe the segment information to be directionally correct, actual results could differ from the estimates and assumptions used in preparing this information.
The accounting policies of the segments are the same as the policies discussed in Footnote B – Summary of Significant Accounting Policies.
We have two reportable operating segments, Laboratory Services and Instrument Business.
 
Segment information for the three months ended June 30, 2011 and 2010 is as follows:
 
 
Dollars in Thousands
 
2011
 
2010
 
Laboratory
Services
 
Instrument
Business
 
Total
 
Laboratory
Services
 
Instrument
Business
 
Total
Net Sales
$
4,866


 
$
2,801


 
$
7,667


 
$
1,241


 
$
3,854


 
$
5,095


Gross Profit
3,064


 
1,491


 
4,555


 
418


 
2,069


 
2,487


Net Loss before Taxes
(5,743
)
 
(359
)
 
(6,102
)
 
(506
)
 
(551
)
 
(1,057
)
Income Tax Expense (Benefit)
—


 
(104
)
 
(104
)
 
—


 
89


 
89


Net Loss
$
(5,743
)
 
$
(255
)
 
$
(5,998
)
 
$
(506
)
 
$
(640
)
 
$
(1,146
)
Depreciation/Amortization
444


 
46


 
490


 
73


 
48


 
121


Restructure
—


 
11


 
11


 
—


 
—


 
—


Interest Income (Expense)
(240
)
 
—


 
(240
)
 
—


 
1


 
1




Segment information for the six months ended June 30, 2011 and 2010 is as follows:


 
Dollars in Thousands
 
2011
 
2010
 
Laboratory
Services
 
Instrument
Business
 
Total
 
Laboratory
Services
 
Instrument
Business
 
Total
Net Sales
$
8,623


 
$
6,525


 
$
15,148


 
$
2,512


 
$
8,025


 
$
10,537


Gross Profit
4,850


 
3,892


 
8,742


 
901


 
4,470


 
5,371


Net Loss before Taxes
(9,278
)
 
392


 
(8,886
)
 
(1,118
)
 
(313
)
 
(1,431
)
Income Tax Expense (Benefit)
—


 
(110
)
 
(110
)
 
—


 
38


 
38


Net Loss
$
(9,278
)
 
$
502


 
$
(8,776
)
 
$
(1,118
)
 
$
(351
)
 
$
(1,469
)
Depreciation/Amortization
872


 
95


 
967


 
152


 
104


 
256


Restructure
—


 
35


 
35


 
—


 
—


 
—


Interest Income (Expense)
(473
)
 
(5
)
 
(478
)
 
—


 
1


 
1


 
6/30/2011
 
6/30/2010
Total Assets
$
22,621


 
$
8,079


 
$
30,700


 
$
7,395


 
$
7,051


 
$
14,446


Net sales by product were as follows:
 
 
Dollars in Thousands
 
Dollars in Thousands
 
Three Months Ended
 
Six Months Ended
 
June 30,
 
June 30,
 
2011
 
2010
 
2011
 
2010
Laboratory Services:
 
 
 
 
 
 
 
Molecular Clinical Reference Laboratory
$
3,864


 
$
931


 
$
7,351


 
$
1,873


Pharmacogenomics Research Services
1,002


 
310


 
1,272


 
639


 
4,866


 
1,241


 
8,623


 
2,512


Instrument Related Business:
 
 
 
 
 
 
 
Bioinstruments
1,319


 
2,217


 
3,157


 
4,569


Bioconsumables
1,482


 
1,637


 
3,368


 
3,456


 
2,801


 
3,854


 
6,525


 
8,025


Total Net Sales
$
7,667


 
$
5,095


 
$
15,148


 
$
10,537


Net cost of goods sold was as follows:
 
 
Dollars in Thousands
 
Dollars in Thousands
 
Three Months Ended
 
Six Months Ended
 
June 30,
 
June 30,
 
2011
 
2010
 
2011
 
2010
Laboratory Services:
 
 
 
 
 
 
 
Molecular Clinical Reference Laboratory
$
1,435


 
$
495


 
$
3,023


 
$
957


Pharmacogenomics Research Services
367


 
328


 
750


 
654


 
1,802


 
823


 
3,773


 
1,611


Instrument Related Business:
 
 
 
 
 
 
 
Bioinstruments
585


 
1,024


 
1,107


 
1,956


Bioconsumables
725


 
761


 
1,526


 
1,599


 
1,310


 
1,785


 
2,633


 
3,555


Total Cost of Goods Sold
$
3,112


 
$
2,608


 
$
6,406


 
$
5,166


 
Net sales for the three and six months ended June 30, 2011 and 2010 by country were as follows:
 
 
Dollars in Thousands
 
Dollars in Thousands
 
Three Months Ended
 
Six Months Ended
 
June 30,
 
June 30,
 
2011
 
2010
 
2011
 
2010
United States
$
5,669


 
$
2,070


 
$
10,705


 
$
4,401


Italy
785


 
721


 
1,611


 
1,487


United Kingdom
233


 
200


 
491


 
767


France
225


 
359


 
413


 
604


Germany
182


 
345


 
394


 
905


United Arab Emirates
—


 
774


 
—


 
774


All Other Countries
573


 
626


 
1,534


 
1,599


Total
$
7,667


 
$
5,095


 
$
15,148


 
$
10,537


No other country accounted for more than 5% of total net sales.


More than 95% of our long-lived assets are within the United States. Substantially all of the remaining long-lived assets are within Europe.